Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus
NCT ID: NCT01163006
Last Updated: 2018-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2010-03-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OPTIFIT-Optimal Fiber Trial for Diabetes Prevention
NCT01681173
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity
NCT01375803
Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM
NCT03741660
Nutritional Prevention of Diabetes Mellitus Type 2
NCT03231839
Study to Investigate the Effect of Dietary Fibre Supplementation on Long-term Glucose Control in Prediabetic Subjects
NCT05157815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
polydextrose
Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre
soluble glucofibre
Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre
isocaloric dietary control
Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre
full caloric control
Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tate and Lyle Ingredients France
INDUSTRY
Maastricht University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maastricht University
Maastricht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC 09-3-084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.